Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Acquires Korean Reagent Distributor

NEW YORK (GenomeWeb News) – Life Technologies today said that it has acquired Korean reagents distributor KDR Biotech for an undisclosed amount.

The Seoul, South Korea-based firm has served as Life Tech's primary reagent distributor in the country since 1982. Life Tech said the deal will allow it to reach a larger customer base in the life sciences market in Korea, and it noted that it will continue to offer other non-Life Tech products that have been part of KDR's portfolio.

"The acquisition of KDR Biotech is in line with Life's Asia-Pacific Japan strategy to further develop customer relationships, improve the customer experience, and increase revenue in the fast-growing South Korean biotechnology market, in addition to Life's overall strategy of expanding our footprint into strong growth and emerging markets," Mark Smedley, president of Life Technologies, Asia-Pacific Japan region, said in a statement.

KDR's current employees will become part of Life Technologies Korea. Its CEO, Jong-moon (Arnold) Kim, will serve as an external advisor to Life Tech during the transition.

Further terms of the deal were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.